FDA Inspection
Hetero Labs LimitedHetero Labs Limited – FDA Inspection, Sep 28, 2018
Record Details
This FDA Inspection record concerns Hetero Labs Limited, with an inspection on September 28, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d0bf55bf-2adb-4de3-93ab-ee8066f88473
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1071152
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Hetero Labs Limited
6| Date | Classification | Office | Project area |
|---|---|---|---|
| January 31, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 8, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 12, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 14, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 29, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hetero Labs Limited
- FDA Inspection 1262652 - 2025-01-31
- FDA Inspection 1217569 - 2023-09-08
- FDA Inspection 1149831 - 2021-08-12
- FDA Inspection 1006040 - 2017-03-14
- FDA Inspection 859017 - 2013-11-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.